57295-18-8 Usage
Description
(1-methylpiperidin-4-yl)methyl hydroxy(diphenyl)acetate is a complex organic chemical compound characterized by the presence of a methylpiperidine group and a hydroxydiphenylacetate group. These structural components are significant in the field of organic chemistry and are often found in pharmaceutical compounds, indicating the potential for this compound to exhibit pharmacological or biological activity.
Uses
Used in Pharmaceutical Industry:
(1-methylpiperidin-4-yl)methyl hydroxy(diphenyl)acetate is used as a precursor or intermediate in the synthesis of various pharmaceutical compounds for its potential pharmacological properties. The presence of the methylpiperidine and hydroxydiphenylacetate groups suggests that it may contribute to the development of drugs targeting specific biological pathways or receptors.
Used in Research and Development:
In the scientific community, (1-methylpiperidin-4-yl)methyl hydroxy(diphenyl)acetate serves as a subject for research and development. It is utilized to explore its chemical properties, reactivity, and potential applications in creating new molecules with therapeutic or other beneficial effects. Further studies are necessary to understand its full potential and to innovate its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 57295-18-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,9 and 5 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 57295-18:
(7*5)+(6*7)+(5*2)+(4*9)+(3*5)+(2*1)+(1*8)=148
148 % 10 = 8
So 57295-18-8 is a valid CAS Registry Number.
57295-18-8Relevant articles and documents
ORGANIC COMPOUNDS
-
Page 31, (2010/02/10)
Compounds of formula (I) in salt or zwitterionic form wherein, wherein R1, R2, R3, R4, R5, J, L and M have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
